Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 31 n° 301

Posts Tagged ‘perkinelmer’

PerkinElmer Receives CE-IVD Mark for Its Vanadis Fully Automated NIPT Platform

Posted by fidest press agency su mercoledì, 28 novembre 2018

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced that its Vanadis® NIPT system has obtained CE-IVD mark for commercialization and distribution throughout Europe and other countries that accept CE marking. This non-invasive test provides screening results for trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome). The Vanadis NIPT system has been validated in an external clinical study conducted in France. The blinded study analyzed 80 samples from pregnancies affected by trisomy 21 and 670 samples from unaffected pregnancies, classifying all cases correctly, with only one sample failing to generate a result. In addition to trisomy 21, PerkinElmer conducted clinical studies to demonstrate high sensitivity and specificity for trisomies 18 and 13.Generally, non-invasive prenatal testing (NIPT) analyzes cell-free DNA (cfDNA) circulating in the maternal blood and has rapidly become the standard follow-up procedure for women classified as high risk following traditional prenatal screening. Measuring cfDNA from a standard blood draw to detect common chromosomal trisomies has been demonstrated with high sensitivity and specificity.“NIPT has been previously limited by the complexity, cost and capacity of existing commercially available technologies, which prevented many laboratories and obstetricians from offering reliable, and cost-effective solutions for aneuploidy screening,” said Olle Ericsson, General Manager at Vanadis Diagnostics, a PerkinElmer company. “With our Vanadis platform, we are taking the technical complexity out of NIPT while breaking down the cost barriers. This will enable more women to gain access to NIPT and improve the level of prenatal care on a global level.”Unlike existing NIPT technologies, which require more complex platforms such as sequencing or microarrays, the Vanadis NIPT platform is the first of its kind designed to simplify screening for trisomies 21, 18 and 13. The Y chromosome can be measured as an optional marker. This cost-effective, high-throughput scalable platform measures fetal chromosomal trisomies in maternal plasma by targeted fluorescent labeling and counting specific cfDNA fragments—removing the costly and data-intensive steps required for gene sequencing or microarray solutions.“The promising results we’ve seen lead us to believe that a broad range of women throughout Europe and around the world now stand to benefit significantly from being able to have NIPT as a key component of prenatal care,” said Jérémie Gautier, head of the project management team at CerbaXpert, which played a leading role in the evaluation study in France.PerkinElmer is also currently collaborating with Women & Infants Hospital (WIH) of Rhode Island, a Care New England hospital, in a clinical validation study to evaluate an innovative test method using the VanadisNIPT system. The VALUE (Validation of a Lower Cost Aneuploidy Screen) study aims to test samples from approximately 2,500 women, most from an average risk pregnancy population, with additional high-risk cases added to determine performance characteristics such as detection rates and false positive rates.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

PerkinElmer to Present at 2018 Citi Global Healthcare Conference

Posted by fidest press agency su venerdì, 23 novembre 2018

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 2018 Citi Global Healthcare Conference on Wednesday, December 5, 2018, at 11:45 a.m. ET at the Lotte New York Palace in New York City.Jamey Mock, PerkinElmer’s senior vice president and chief financial officer, will provide an overview of the Company and its strategic priorities.A live audio webcast of the presentation will also be available on the Investors section of the Company’s website at http://www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer website after the event and will be available for two weeks following.
PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.3 billion in 2017, has about 11,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

PerkinElmer to Present at Morgan Stanley Global Healthcare Conference

Posted by fidest press agency su martedì, 28 agosto 2018

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 16th annual Morgan Stanley Global Healthcare Conference on Friday, September 14, 2018 at 11:40 a.m. ET at the Grand Hyatt New York in New York City.Robert F. Friel, PerkinElmer’s chairman and chief executive officer, will provide an overview of the Company and its strategic priorities.A live audio webcast of the presentation will also be available on the Investors section of the Company’s website at http://www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer website after the event and will be available for two weeks following.
PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.3 billion in 2017, has about 11,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at http://www.perkinelmer.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

PerkinElmer to Hold Earnings Call on Monday, April 30, 2018

Posted by fidest press agency su mercoledì, 11 aprile 2018

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that on Monday, April 30, 2018, after market close, the Company will release first quarter 2018 results. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss these results. Robert Friel, chairman and chief executive officer, and Andy Wilson, senior vice president and chief financial officer, will host the conference call.
To access the call, please dial (541) 797-2422 prior to the scheduled conference call time and provide the access code 3478837. A live audio webcast of the call will also be available on the Investors section of the Company’s Web site at http://www.perkinelmer.com.
PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.3 billion in 2017, has about 11,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at http://www.perkinelmer.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

PerkinElmer to Present at Cowen and Company 38th Annual Health Care Conference

Posted by fidest press agency su venerdì, 2 marzo 2018

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Cowen and Company 38th Annual Health Care Conference on Monday, March 12, 2018 at 2:50 pm ET at the Marriott Copley Place in Boston.
Robert F. Friel, PerkinElmer’s chairman and chief executive officer, will provide an overview of the Company and its strategic priorities.A live audio webcast of the presentation will also be available on the Investors section of the Company’s website at http://www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer website after the event and will be available for two weeks following.
PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.3 billion in 2017, has about 11,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at http://www.perkinelmer.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

PerkinElmer to Present at Morgan Stanley Global Healthcare Conference

Posted by fidest press agency su venerdì, 1 settembre 2017

new yorkNew York. PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 15th annual Morgan Stanley Global Healthcare Conference on Monday, September 11, 2017 at 11:40 am ET at the Grand Hyatt New York. Robert Friel, PerkinElmer’s chairman and chief executive officer, will provide an overview of the Company and its strategic objectives.A live audio webcast of the presentation will also be available on the Investors section of the Company’s website at http://www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer website after the event and will be available for two weeks following.PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Our dedicated team of 9,000 employees worldwide is passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics, discovery and analytical solutions markets. Our innovative detection, imaging, informatics and service capabilities, combined with deep market knowledge and expertise, help customers gain earlier and more accurate insights to improve lives and the world around us. The Company reported revenue of approximately $2.1 billion in 2016, serves customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at http://www.perkinelmer.com

Posted in Economia/Economy/finance/business/technology, Estero/world news, Uncategorized | Contrassegnato da tag: , | Leave a Comment »